Lens (anatomy)

National Vision Holdings, Inc. (EYE) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against National Vision Holdings, Inc.

Retrieved on: 
Tuesday, February 7, 2023
CSS, Lens (anatomy), Optometry, Complaint, EPS, Operational definition, Qatar National Vision 2030, Glasses, EYE, News, Security (finance), Risk management

What Now: Similarly situated shareholders may be eligible to participate in the class action against National Vision.

Key Points: 
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against National Vision.
  • Shareholders who want to act as lead plaintiff for the class must file their papers by March 28, 2023.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • On May 10, 2022, National Vision issued deeply disappointing financial and operational results for its first fiscal quarter of 2022.

NATIONAL VISION HOLDINGS, INC. (NASDAQ: EYE) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against National Vision Holdings, Inc. (NASDAQ: EYE)

Retrieved on: 
Tuesday, February 7, 2023
CSS, Lens (anatomy), Optometry, COVID-19, The Legal 500, EPS, Advertising, Court, Labour government, District court, Investment, Qatar National Vision 2030, Glasses, EYE, News, Security (finance)

NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of National Vision Holdings, Inc. (“National Vision” or the “Company”) (NASDAQ: EYE) between May 13, 2021 and May 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of Georgia and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Joseph R. Seidman, Jr. at (877) 779-1414 or [email protected] to discuss your rights.
  • National Vision is an optical retailer that provides eye exams, eyeglasses, and contact lenses to value-seeking and lower-income consumers.
  • On May 10, 2022, National Vision issued deeply disappointing financial and operational results for its first fiscal quarter of 2022.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

NATIONAL VISION HOLDINGS, INC. (NASDAQ: EYE) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against National Vision Holdings, Inc. (NASDAQ: EYE)

Retrieved on: 
Thursday, February 2, 2023
CSS, Lens (anatomy), Optometry, COVID-19, The Legal 500, EPS, Advertising, LLP, Court, Labour government, District court, Investment, Qatar National Vision 2030, Glasses, EYE, News, Security (finance)

NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the common stock of National Vision Holdings, Inc. (“National Vision” or the “Company”) (NASDAQ: EYE) between May 13, 2021 and May 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of Georgia and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • National Vision is an optical retailer that provides eye exams, eyeglasses, and contact lenses to value-seeking and lower-income consumers.
  • On May 10, 2022, National Vision issued deeply disappointing financial and operational results for its first fiscal quarter of 2022.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of National Vision Holdings, Inc. (EYE) Investors and Encourages Investors to Contact the Firm Before March 28, 2023

Retrieved on: 
Wednesday, February 1, 2023
Lens (anatomy), COVID-19, Kirby, Court, District court, Investment, Qatar National Vision 2030, Douglas v. U.S. District Court ex rel Talk America, Glasses, EYE, News, Pharmaceutical industry, Private investigator

Investors have until March 28, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until March 28, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • National Vision operates as an optical retailer, which provides eye exams, eyeglasses, and contact lenses.
  • On May 10, 2022, National Vision issued deeply disappointing financial and operational results for its first fiscal quarter of 2022.
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against National Vision Holdings, Inc. (EYE)

Retrieved on: 
Tuesday, January 31, 2023
Complaint, Lens (anatomy), COVID-19, Person, District court, Qatar National Vision 2030, Glasses, EYE, Private investigator

National Vision is an optical retailer that provides eye exams, eyeglasses, and contact lenses to value-seeking and lower-income consumers.

Key Points: 
  • National Vision is an optical retailer that provides eye exams, eyeglasses, and contact lenses to value-seeking and lower-income consumers.
  • One of the most important components of National Vision’s operations and prospects is National Vision’s ability to recruit and retain specialized staff and healthcare providers, in particular optometrists.
  • Investors who purchased or otherwise acquired shares of National Vision should contact the Firm prior to the March 28, 2023 lead plaintiff motion deadline.
  • If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.

Thailand Contact Lenses Market Report 2023-2028: Featuring Bausch & Lomb, Maxim Inter-Corp, Johnson & Johnson & Alcon Laboratories - ResearchAndMarkets.com

Retrieved on: 
Monday, January 16, 2023
Health, Optical, Lens (anatomy), Bausch & Lomb, Alcon, Growth, Presbyopia, Work

The "Thailand Contact Lenses Market 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Thailand Contact Lenses Market 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The publisher highlights that the Thailand contact lenses market is anticipated to register growth at CAGRs of 8.56% by revenue and 8.67% by volume over the forecast period 2023-2028.
  • Thus, these initiatives taken by market players are expected to increase sales, thereby driving the market during the forecast period.
  • The established players in the Thai contact lenses market are Johnson & Johnson (Thailand) Ltd, Ciba Vision (Thailand) Ltd, Maxim Inter-Corp Co Ltd, Bausch & Lomb (Thailand) Co Ltd, and Alcon Laboratories (Thailand) Ltd.

Having Committed to Growth in the New Year, Unicoeye Accelerates Its Online Expansion

Retrieved on: 
Friday, January 13, 2023
Severe cognitive impairment, Lens (anatomy), Social media, Criticism of the Food and Drug Administration, Eye color, Eye injury, Public health, Safety, FDA, Pharmacy, Growth, Food, Lens, Research, Cosmetics

WHIPPANY, N.J., Jan. 13, 2023 /PRNewswire/ -- Unicoeye, an online retailer of colored contact lenses, is entering the new year with the ambitious goal of accelerating its online expansion.

Key Points: 
  • WHIPPANY, N.J., Jan. 13, 2023 /PRNewswire/ -- Unicoeye, an online retailer of colored contact lenses, is entering the new year with the ambitious goal of accelerating its online expansion.
  • The company is committed to achieving growth in 2023 and is taking the necessary steps to ensure this goal is met.
  • To achieve its planned online expansion, Unicoeye has decided to start by adjusting product prices and hosting promotions.
  • "With the right approach, we are confident that we can reach our goals of online expansion and overall growth this year."

Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses

Retrieved on: 
Wednesday, January 11, 2023
Medical Devices, Surgery, Women, Entertainment, Men, Celebrity, General Health, Consumer, Health, Optical, Netflix, American Society of Cataract and Refractive Surgery, Lens (anatomy), ASCRS, Literature, Quality, Learning, Ophthalmology, Nave, Glasses, FDA, Myopia, Partnership, EVO, Prevalence, Night vision, Paramount+, Lens, Dry eye syndrome, Iris, Astigmatism, School Spirits, Society, Refractive surgery, Multimedia, Eye, Cataract, Intraocular lens, Medical device, Telescopic sight, LASIK, Patient, Life

EVO is an FDA-approved vision correction lens designed for the correction/reduction of myopia with or without astigmatism.

Key Points: 
  • EVO is an FDA-approved vision correction lens designed for the correction/reduction of myopia with or without astigmatism.
  • View the full release here: https://www.businesswire.com/news/home/20230111005302/en/
    Peyton List, actress and entrepreneur, sets her sights on a new acting role without the hassles of eyeglasses and contact lenses thanks to her new EVO ICL lenses - a life-changing vision correction lens designed for the correction/reduction of myopia (nearsightedness) and astigmatism.
  • Recently, List had EVO lenses implanted by her doctor to upgrade her vision.
  • List went from struggling with the hassles of contact lenses, both on and off the film set, to having clear 20/20 vision following the EVO procedure.

Global Eyewear Market 2022 to 2031 - Featuring Luxottica Group, Essilor International, Zeiss International and Johnson & Johnson Vision Care Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 10, 2023
Health, Optical, Benchmark, News, Visual impairment, Lens (anatomy), IOS, Eyewear, World Health Organization, Create, Spondyloarthropathy, WHO, Smartglasses, Glaucoma, Luxottica, Organization, Woman, Cataract, Growth, Prevalence, Bluetooth, Diabetic retinopathy, Coronavirus, Dust, Fielmann AG, Acquisition, Android, Traction, Hoya Corporation, Renewable energy, Marketing, Telescopic sight, Mobile phone, Titan

This report provides strategists, marketers and senior management with the critical information they need to assess the global eyewear market.

Key Points: 
  • This report provides strategists, marketers and senior management with the critical information they need to assess the global eyewear market.
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • The regions covered in eyewear market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • The countries covered in the eyewear market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

South Korea Contact Lenses Market 2023 to 2028: Featuring Alcon Korea, Johnson & Johnson Korea, CooperVision Korea, Interojo and Bausch & Lomb Korea - ResearchAndMarkets.com

Retrieved on: 
Monday, January 9, 2023
Health, Optical, LASEK, Lens (anatomy), Growth, SMILE, Ith, Bausch, Food delivery, Thermoplastic, LASIK

IThe "South Korea Contact Lenses Market 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • IThe "South Korea Contact Lenses Market 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The South Korea contact lenses market is anticipated to grow at CAGRs of 3.15% by revenue and 2.76% by volume during the forecast period 2023-2028.
  • Compared to other countries, South Korea has high sales of conventional lenses.
  • The established players in the South Korean contact lenses market include Alcon Korea Ltd, Johnson & Johnson Korea Co Ltd, CooperVision Korea Inc, Interojo Inc, and Bausch & Lomb Korea Inc.